The Latest Breaking News from MHRA

A “next generation” Covid-19 booster jab which is the first to target two strains of the virus has been approved for use in adults in the UK.The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Moderna’s bivalent vaccine, which targets both the original Covid strain and the Omicron variant.Known…

The new booster vaccine from Moderna is the Spikevax bivalent Original/Omicron. It will target the original virus strain from 2020 and Omicron.

The UK has become the first country to approve the new booster, which is said will help protect people from Covid over the winter

A new coronavirus booster jab has been approved for use in adults.

New vaccine is a ‘sharpened tool in our armoury’ to fight against Covid, says Dr June Raine, chief for the UK medicines regulator

Moderna's chief medical officer, Dr Paul Burton, previously said that the new jab can boost a person's antibodies to such high levels that it may only be needed annually

The ‘next generation’ Moderna jab may only need to be administered once a year

Britain, the first country to approve a coronavirus vaccine in late 2020, has now also given the first green light to a variant-adapted shot that targets both the original and Omicron version of the virus.

The new Moderna vaccine could put an end to three or four injections a year - and fights Omicron